Análisis Argos
ALC
ALCCara
Alcon Inc. · Healthcare
US$ 69.11
precio al 2026-07-28
Valor justo Argos*
US$ 66
vs. su valor justo
▼−5%
Score Argos
45/100
LA RESPUESTA
El mercado le pide crezca 60% al año — más de lo que ha demostrado (4.2%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
Sin recompensas destacadas.
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
!Crecimiento estancado o en baja.
VALOR1/6FUTURO2/6PASADO2/6SALUD3/6DIVIDENDO3/6
El Iris de calidad
VALOR1/6FUTURO2/6PASADO2/6SALUD3/6DIVIDENDO3/6
ValorCotiza por encima de su valor justo
FuturoCrecimiento moderado
PasadoHistorial aceptable
SaludBalance razonable
DividendoRetorno al accionista moderado
Score Argos45de 100Cara
Ingresos▲5%
US$ 10.4 B
Margen operativo▼8%
13.1%
Flujo de caja libre▲14%
US$ 1.6 B
Deuda neta
US$ 3.7 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 33.7B
P/E34.4x
EV/EBITDA14.7x
FCF yield4.8%
ROIC4.5%
Margen operativo13.1%
Crecim. ingresos+4.9%/año
Piotroski F5/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

zacks.com · 22 jul
Alcon (ALC) is a Top-Ranked Momentum Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zacks.com · 17 jul
3 Medical Instrument Stocks Betting on GenAI to Ease Industry Hurdles
GenAI creates new opportunities for ISRG, ALC and LIVN, even as regulatory, inflation and industry headwinds continue to pressure MedTech.
zacks.com · 14 jul
Why Alcon (ALC) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zacks.com · 14 jul
Buy 3 AI-Led Medical Devices Laggards of 1H Set to Gather Pace in 2H
ISRG, IDXX and ALC are three AI-driven medical device laggards with strong business momentum and improving earnings estimates for a potential 2H rebound.
zacks.com · 13 jul
Alcon & RxSight Collaborate to Develop Adjustable PCIOL Technology
ALC is developing adjustable presbyopia-correcting lenses that pair advanced optics with post-surgery light adjustment.
zacks.com · 13 jul
DELL & 3 More Stocks With Strong Interest Coverage to Buy Now
DELL, Brinker International, Tapestry and Alcon pair strong interest coverage with solid growth prospects amid elevated borrowing costs.
marketbeat.com · 10 jul
RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook
RxSight NASDAQ: RXST reported preliminary second-quarter financial results and provided updates on its product pipeline following a newly announced strategic collaboration agreement with Alcon, with management pointing to both near-term commercial headwinds and longer-term opportunities in adjustable intraocular lenses.
zacks.com · 9 jul
Wall Street Analysts Predict a 27.75% Upside in Alcon (ALC): Here's What You Should Know
The mean of analysts' price targets for Alcon (ALC) points to a 27.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.